Insider Transactions in Q2 2022 at Iveric Bio, Inc. (ISEE)
Insider Transaction List (Q2 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 30
2022
|
Anthony S Gibney EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+50.0%
|
-
|
Jun 13
2022
|
Calvin W. Roberts Director |
BUY
Open market or private purchase
|
Direct |
25,000
+43.48%
|
$225,000
$9.62 P/Share
|
May 11
2022
|
Mark S. Blumenkranz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+37.5%
|
-
|
May 11
2022
|
Calvin W. Roberts Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
-
|
May 11
2022
|
Axel Bolte Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
-
|
May 11
2022
|
Jane Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
-
|
May 11
2022
|
Adrienne L Graves Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
-
|
May 03
2022
|
Pravin Dugel President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,313
+3.65%
|
-
|
Apr 18
2022
|
Keith Westby SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.16%
|
$160,000
$16.63 P/Share
|
Apr 05
2022
|
Keith Westby SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,298
-7.85%
|
$176,662
$19.02 P/Share
|
Apr 05
2022
|
Keith Westby SVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,298
+7.28%
|
$9,298
$1.45 P/Share
|
Apr 05
2022
|
David Francis Carroll SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,684
-10.44%
|
$88,996
$19.01 P/Share
|
Apr 05
2022
|
David Francis Carroll SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,684
+9.46%
|
$4,684
$1.45 P/Share
|
Apr 04
2022
|
Glenn Sblendorio Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-17.88%
|
$900,000
$18.76 P/Share
|
Apr 04
2022
|
Keith Westby SVP, Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
20,702
-15.95%
|
$393,338
$19.0 P/Share
|
Apr 04
2022
|
Keith Westby SVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,702
+13.75%
|
$20,702
$1.45 P/Share
|
Apr 04
2022
|
David Francis Carroll SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
40,941
-25.6%
|
$736,938
$18.75 P/Share
|
Apr 04
2022
|
David Francis Carroll SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,316
+20.03%
|
$20,316
$1.45 P/Share
|
Apr 01
2022
|
Pravin Dugel President |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+31.31%
|
-
|
Apr 01
2022
|
David Francis Carroll SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,144
-3.41%
|
$36,448
$17.0 P/Share
|
Apr 01
2022
|
Glenn Sblendorio Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
40,756
-12.72%
|
$692,852
$17.5 P/Share
|
Apr 01
2022
|
Glenn Sblendorio Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,756
+11.28%
|
$81,512
$2.94 P/Share
|